Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-29
2009-08-18
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252140, C514S269000, C544S295000, C544S310000, C540S575000
Reexamination Certificate
active
07576076
ABSTRACT:
The present invention provides a compound having the formula:wherein, n and m are1; X1and X2are O; R1is a member selected from unsubstituted phenyl and substituted phenyl; R2is a member selected from hydrogen, —CN, —OR2A, -L2A—C(O)R2B, -L2B—S(O)2R2C; R3is a member selected from unsubstituted benzyl and substituted benzyl; R4is a member selected from hydrogen and substituted or unsubstituted alkyl, wherein if R4is methyl, then -L1-R1is not benzyl or —C(O)—O—CH2—CH3; and L1is a bond; and compositions and methods of using the compounds as glucocorticoid receptor modulators.
REFERENCES:
patent: 6852719 (2005-02-01), Liu et al.
patent: 0037495 (1981-10-01), None
patent: 0369627 (1990-05-01), None
patent: 0722732 (1996-07-01), None
patent: 06128238 (1994-05-01), None
patent: 10017555 (1998-01-01), None
patent: WO02/44120 (2002-06-01), None
patent: WO03/084935 (2003-10-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim pg. IX of Preface.
Teutsch G., et al. “Design of ligands for the glucocortoid and progestin receptors”,Biochemical Society Transactions(1991) 19(4):901-908.
Fukazawa, Nobuyuki, et al. “6-Amino-5-methyluracil derivatives and their use as thymidine phosphorylase inhibitors and neovascularization inhibitors”, XP002355358; Database CA ‘Online’; Chemical Abstracts Service, Columbus, OH, US; Database accession No. 1998:59356, Abstract.
Bhuyan, Pulak J., et al. “Studies on Uracils: Synthesis of Novel Uracil Analogs via 1,5- and 1,6-Intramolecular Cycloadditional Reactions”, XP002355359; Database CA ‘Online’; Chemical Abstracts Service, Columbus, OH, US; Database accession No. 1998:598911, Abstract.
Clark David A.
Clark Robin D.
Crackett Peter H.
Hickin Gwen
Ray Nicolas C.
Corcept Therapeutics, Inc.
Murray Jeffrey H
Townsend and Townsend / and Crew LLP
Wilson James O
LandOfFree
Modified pyrimidine glucocorticoid receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified pyrimidine glucocorticoid receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified pyrimidine glucocorticoid receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4060736